Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,681.41
(
-0.52%
)
US TECH 100
24,051.20
(
-0.34%
)
Dow Jones
46,606.40
(
-0.82%
)
Brent Oil
105.73
(
5.05%
)
Bitcoin
71,284.42
(
-3.59%
)
News Focus
News Focus

Replies to post #10264 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #10264 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

DewDiligence

02/07/13 7:09 PM

#10267 RE: joethdo #10264

The Copaxone ANDA has been at the FDA for 62 months (since Dec 2007) and has been under active review for 55 months (since Jul 2008). The FDA took 59 months to approve MNTA’s Lovenox ANDA.